{"id":"W2604822177","doi":"10.1007/s00277-017-2982-1","title":"Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia","year":2017,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Ottawa Hospital; BC Cancer Agency; Université Laval; University of Calgary; McGill University Health Centre","funders":"","keywords":"Ibrutinib; Chemoimmunotherapy; Medicine; Fludarabine; Venetoclax; Idelalisib; Chronic lymphocytic leukemia; Alemtuzumab; Rituximab; Oncology; Internal medicine; Hematology; Cyclophosphamide; Salvage therapy; Transplantation; Leukemia; Immunology; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005045679,0.0005041488,0.004426936,0.0004724752,0.00006045125,0.000008734136,0.0008157656,0.0006276477,0.00007574633],"category_scores_gemma":[0.0004070628,0.0002913724,0.0009362358,0.0002663883,0.000796538,0.00009648612,0.00008053057,0.0003274906,0.00007168743],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01678688,"about_ca_system_score_gemma":0.05875503,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006100758,"about_ca_topic_score_gemma":0.000146129,"domain_scores_codex":[0.9965041,0.0003930721,0.00138583,0.0005324087,0.000514906,0.0006697115],"domain_scores_gemma":[0.9950511,0.001473269,0.00120036,0.002042209,0.000124696,0.000108311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001369317,0.0002820613,0.000006497353,0.04839116,0.0003392707,0.0009842301,0.0002345231,0.000003842428,7.048117e-7,0.001535326,0.0006655988,0.9474198],"study_design_scores_gemma":[0.005532921,0.002274629,0.000002515839,0.01516549,0.0004949106,0.00244822,0.00003710014,0.00005972709,0.0001174371,0.0001739045,0.9734989,0.0001942794],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003883601,0.9919683,0.000001914024,0.00006795047,0.0001664615,0.001468316,0.00002604696,0.00001496553,0.005897675],"genre_scores_gemma":[0.003916834,0.9951678,0.00001863903,0.00003760467,0.0001539948,0.0002630848,0.00007754731,0.00005450492,0.0003100267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9728333,"threshold_uncertainty_score":0.9999539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1847946804722722,"score_gpt":0.4725117241757338,"score_spread":0.2877170437034616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}